99
Participants
Start Date
December 19, 2007
Primary Completion Date
December 20, 2008
Study Completion Date
January 7, 2009
RN624
50 mcg/kg
RN624
200 mcg/kg
Placebo
placebo
Allegheny Pain Management, PC, Altoona
International Research Center, Towson
National Clinical Research, Incorporated, Richmond
Asheville Neurology Specialists, PA, Asheville
Miami Medical Associates, Miami
Neurology Clinical Research, Inc., Sunrise
Palm Beach Neurological Center, Advanced Research Consultants, Inc., Palm Beach Gardens
Jem Research, LLC, Atlantis
Meridien Research, Tampa
Clinical Research of West Florida, Clearwater
Innovative Research of West Florida, Inc., Largo
Anniston Medical Clinic/Pinnacle Research Group LLC, Anniston
Anniston Neurology & Headache Mgmt. Ctr., Anniston
Rapid Medical Research, Inc., Cleveland
Wells Institute for Health Awareness, Kettering
Hometown Urgent Care and Research, Dayton
Michigan Head Pain and Neurological Institute, Ann Arbor
Medical Advanced Pain Specialists (MAPS), Edina
A & A Pain Institute, St Louis
Cotton-O'Neil Clinical Research, Topeka
Cotton-O'Neil Clinic, Topeka
Neurological Clinic of Texas, Dallas
Mobley Research Center, Houston
DiscoveResearch Incorporated, Bryan
Clinical Trials of Texas, Inc., San Antonio
Jay Ellis Jr., MD-Tejas Anesthesia, San Antonio
Radiant Research San Antonio Northeast, San Antonio
Arizona Research Center, Phoenix
Dedicated Clinical Research, Inc., Litchfield Park
Infinity Medical Research, Inc., North Dartmouth
Altoona Center for Clinical Research, Duncansville
Lead Sponsor
Pfizer
INDUSTRY